journal article·2013-05-17Open access

Citrate-Linked Keto- and Aldo-Hexose Monosaccharide Cellulose Conjugates Demonstrate Selective Human Neutrophil Elastase-Lowering Activity in Cotton Dressings

Judson Edwards, Sonya Caston-Pierre

Abstract

Sequestration of harmful proteases as human neutrophil elastase (HNE) from the chronic wound environment is an important goal of wound dressing design and function. Monosaccharides attached to cellulose conjugates as ester-appended aldohexoses and ketohexoses were prepared on cotton gauze as monosccharide-citrate-cellulose-esters for HNE sequestration. The monosaccharide-cellulose analogs demonstrated selective binding when the derivatized cotton dressings were measured for sequestration of HNE. Each monosaccharide-cellulose conjugate was prepared as a cellulose citrate-linked monosaccharide ester on the cotton wound dressing, and assayed under wound exudate-mimicked conditions for elastase sequestration activity. A series of three aldohexose and four ketohexose ester cellulose conjugates were prepared on cotton gauze through citric acid-cellulose cross linking esterification. The monosaccharide portion of the conjugate was characterized by hydrolysis of the citrate-monosaccharide ester bond, and subsequent analysis of the free monosaccharide with high performance anion exchange chromatography. The ketohexose and aldohexose conjugate levels on cotton were quantified on cotton using chromatography and found to be present in milligram/gram amounts. The citrate-cellulose ester bonds were characterized with FTIR. Ketohexose-citrate-cellulose conjugates sequestered more elastase activity than aldohexose-citrate-cellulose conjugates. The monosaccharide cellulose conjugate families each gave distinctive profiles in elastase-lowering effects. Possible mechanisms of elastase binding to the monosaccharide-cellulose conjugates are discussed.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Surgical Sutures and Adhesives · Hemostasis and retained surgical items

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

USDA-ARS, Southern Regional Research Center, 1100 Robert E. Lee Blvd., New Orleans, LA 70124, USA

Dillard University, 2601 Gentilly Boulevard, New Orleans, LA 70122, USA

References (53)

Show source-provided references
1. Occlusive wound dressings. Why, when, which?10.1001/archderm.1988.01670060018009 ↗
2. Wound dressings in diabetic foot disease10.1086/383270 ↗
3. Fibres for wound dressings based on mixed carbohydrate polymer fibres10.1016/S0144-8617(03)00108-5 ↗
4. Treatment of a venous leg ulcer with a honey alginate dressing10.12968/bjcn.2005.10.Sup2.18175 ↗
5. Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing10.1016/S0142-9612(02)00100-X ↗
6. Scaffold: A novel carrier for cell and drug delivery10.1615/CritRevTherDrugCarrierSyst.v29.i1.10 ↗
7. Hyaluronic acid derivatives and their healing effect on burns, epithelial surgical wounds, and chronic wounds: A systematic review and meta-analysis of randomized controlled trials10.1111/j.1524-475X.2012.00777.x ↗
8. Edwards, J.V., Buschle-Diller, G., and Goheen, S.C. (2006). Modified Fibers with Medical and Specialty Applications, Springer.10.1007/1-4020-3794-5 ↗
9. Effectiveness of beta-glucan collagen for treatment of partial-thickness burns in children10.1053/jpsu.2001.20024 ↗
10. Polysaccharide fibers in wound management
11. Mechanical properties of bacterial cellulose and interactions with smooth muscle cells10.1016/j.biomaterials.2005.10.026 ↗
12. Protease and ROS activities influenced by a composite of bacterial cellulose and collagen type I in vitro10.1007/s10570-006-9073-0 ↗
13. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers10.1046/j.1524-475X.2002.10703.x ↗
14. The influence of hydrophilizing agents on gel formation rate of cellulose derivatives. Part 3: Effect of hydrophilizing agents and of polymer type on the release rate of hydrocortisone form xerogel dressing
15. Polymer-xerogel composites for controlled release wound dressings10.1016/j.biomaterials.2010.04.065 ↗
16. Skin physiology and textiles – Consideratoin of basic interactions10.1159/000093926 ↗
17. Thomas, S. (1990). Wound Management and Dressings, The Pharmaceutical Press.
18. Development of alginate wound dressings with hybrid peptides derived from lamin and elastin10.1016/j.biomaterials.2003.07.004 ↗
19. Human Neutrophil Elastase Innhibition with a Novel Cotton-Alginate Wound Dressing Formulation10.1002/jbm.a.10517 ↗
20. Dumville, J.C., Deshpande, S., O’Meara, S., and Speak, K. (2012). Alginate dressings for healing diabetic foot ulcers. Chochrane Database of Syst. Rev., 2.10.1002/14651858.CD009110.pub2 ↗
21. Application of chitin and chitosan derivatives in the pharmaceutical field10.2174/1389201033489748 ↗
22. Biomaterials based on chitin and chitosan in wound dressing applications10.1016/j.biotechadv.2011.01.005 ↗
23. Development of novel chitin/nanosilver composite scaffolds for wound dressing applications
24. Hydrogels for pharmaceutical and biomedical applications10.1615/CritRevTherDrugCarrierSyst.v22.i2.10 ↗
25. Novel wound sealants: Biomaterials and applications10.1586/erd.10.40 ↗
26. Dressing for acute and chronic wounds: A systematic review10.1001/archderm.143.10.1297 ↗
27. Modified cotton gauze dressings that selectively absorb neutrophil elastase activity in solution10.1046/j.1524-475x.2001.00050.x ↗
28. Design, preparation and assessment of citrate-linked monosaccharide cellulose conjugates with elastase-lowering activity10.1016/S0144-8617(02)00029-2 ↗
29. Human neutrophil elastase and collagenase sequestration with phosphorylated cotton wound dressings10.1002/jbm.a.31171 ↗
30. The proteolytic environment of chronic wounds10.1046/j.1524-475X.1999.00433.x ↗
31. Characterization of potential elastase inhibitor-peptides regulated by a molecular switch for wound dressing applications10.1016/j.enzmictec.2011.10.006 ↗
32. Synthesis and activity of NH2- and COOH-terminal elastase recognition sequences on cotton10.1034/j.1399-3011.1999.00134.x ↗
33. Superabsorbent polymer-containing wound dressings have a beneficial effect on wound healing by reducing PMN elastase concentration and inhibiting microbial growth10.1007/s10856-011-4423-3 ↗
34. Meyer-Ingold, W., Eichner, W., Ettner, N., and Schink, M. (2000). Wound coverings for removal of interfering factors from wound fluid. (6156334), U.S. Patent.
35. Attenuation of protease activity in chronic wound fluid with bisphosphonate-functionalised hydrogels10.1016/j.biomaterials.2007.12.043 ↗
36. Novel sulfonated hydrogel composite with the ability to inhibit proteases and bacterial growth10.1002/jbm.a.30440 ↗
37. A novel property of povidon-iodine: Inhibition of excessive protease levels in chronic non-healing wounds10.1038/sj.jid.5700474 ↗
38. Inhibition of elastase by a synthetic cotton-bound serine protease inhibitor: In vitro kinetics and inhibitor release10.1046/j.1524-475X.1999.00106.x ↗
39. Protease inhibition by oleic acid transfer from chronic wound dressing to albumin10.1016/j.ijpharm.2007.03.018 ↗
40. Early healing events in a procine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing10.1046/j.1524-475X.2002.10308.x ↗
41. Gelatin microspheres cross-linked with EDC as a drug delivery system for doxycyline: development and characterization10.1080/02652040701500137 ↗
42. Characterizing ester crosslinkages in cotton cellulose with FT-IR photoacoustic spectroscopy10.1177/004051759106100509 ↗
43. X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor10.1002/j.1460-2075.1986.tb04521.x ↗
44. Epimeric monosaccharide-quinone hybrids on gold electrodes toward the electrochemical probing of specific carbohydrate-protein recognitions10.1021/ja110478j ↗
45. Structure and energetics of protein carbohydrate complexes10.1016/S0959-440X(94)90170-8 ↗
46. New aspects of the Maillard reaction in foods and in the human body10.1002/anie.199005653 ↗
47. Structure and Mechanism of Chymotrypsin10.1021/ar50100a004 ↗
48. Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity and mechanism-based inhibitors10.1021/bi00431a001 ↗
49. On the active site of elastase: Partial mapping by means of specific peptide substrates10.1016/0014-5793(70)80548-8 ↗
50. Inhibition of human leucocyte elastase by ursolic acid. Evidence for a binding site for pentacyclic triterpenes10.1042/bj2770521 ↗
51. Analysis of an enzyme substrate complex10.1021/bi00402a035 ↗
52. Synthetic inhibitors of elastase10.1002/med.2610140202 ↗
53. Crystallographie study of a β-lactam inhibitor complex with elastase at 1.84 Å resolution10.1038/327079a0 ↗